QNRX — Quoin Pharmaceuticals, Ltd. American Depositary Shares
XNAS · Healthcare · Biotechnology
Price$5.06
Market Cap$10.2M
P/E—
52W Range$4.55 – $41.80
Next Earnings2026-08-06
About Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.